Press "Enter" to skip to content

Brazil Defends Rejection of Russia’s Sputnik Vaccine

File picture of a vial labelled Sputnik V. (Reuters)

Sputnik V mentioned earlier Thursday it was “undertaking a legal defamation proceeding in Brazil against Anvisa for knowingly spreading false and inaccurate information.”

  • AFP
  • Last Updated:April 30, 2021, 08:12 IST

Brazil’s nationwide well being regulator mentioned Thursday its choice to reject the Russian-made Sputnik V vaccine was primarily based on the developer’s personal knowledge, after the latter threatened to sue for defamation.

The Brazilian company, Anvisa, primarily based the choice on proof the vaccine carried a reside model of a typical cold-causing virus — data it mentioned “was submitted by the Sputnik V vaccine developer itself.”

The choice to disclaim emergency use authorization for the vaccine, introduced Monday, has blown up into an all-out worldwide row.

Sputnik V mentioned earlier Thursday it was “enterprise a authorized defamation continuing in Brazil in opposition to Anvisa for knowingly spreading false and inaccurate data.”

“Anvisa made incorrect and deceptive statements with out having examined the precise Sputnik V vaccine,” it tweeted.

The regulator fired again defensively in a press convention.

“Anvisa was accused of mendacity, of appearing unethically, of disseminating faux information about replicating adenovirus,” mentioned the company’s director, Antonio Barra Torres.

“We refute this grave accusation.”

Read all of the Latest News and Breaking News right here

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: